Literature DB >> 20881048

Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys.

Clement Wesley Gnanadurai1, Ivona Pandrea, Nicholas F Parrish, Matthias H Kraus, Gerald H Learn, Maria G Salazar, Ulrike Sauermann, Katharina Töpfer, Rajeev Gautam, Jan Münch, Christiane Stahl-Hennig, Christian Apetrei, Beatrice H Hahn, Frank Kirchhoff.   

Abstract

Understanding the lack of disease progression in nonpathogenic simian immunodeficiency virus (SIV) infections is essential for deciphering the immunopathogenesis of human AIDS. Yet, in vivo studies have been hampered by a paucity of infectious molecular clones (IMCs) of SIV suitable to dissect the viral and host factors responsible for the nonpathogenic phenotype. Here, we describe the identification, cloning, and biological analysis of the first transmitted/founder (T/F) virus representing a nonpathogenic SIV infection. Blood was collected at peak viremia from an acutely infected sabaeus monkey (Chlorocebus sabaeus) inoculated intravenously with an African green monkey SIV (SIVagm) strain (Sab92018) that had never been propagated in vitro. To generate IMCs, we first used conventional (bulk) PCR to amplify full-length viral genomes from peripheral blood mononuclear cell (PBMC) DNA. Although this yielded two intact SIVagmSab genomes, biological characterization revealed that both were replication defective. We then performed single-genome amplification (SGA) to generate partially overlapping 5' (n = 10) and 3' (n = 13) half genomes from plasma viral RNA. Analysis of these amplicons revealed clusters of nearly identical viral sequences representing the progeny of T/F viruses. Synthesis of the consensus sequence of one of these generated an IMC (Sab92018ivTF) that produced infectious CCR5-tropic virions and replicated to high titers in Molt-4 clone 8 cells and African green monkey PBMCs. Sab92018ivTF also initiated productive infection in sabaeus monkeys and faithfully recapitulated the replication kinetics and nonpathogenic phenotype of the parental Sab92018 strain. These results thus extend the T/F virus concept to nonpathogenic SIV infections and provide an important new tool to define viral determinants of disease nonprogression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881048      PMCID: PMC2976391          DOI: 10.1128/JVI.01603-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  High virus loads in naturally and experimentally SIVagm-infected African green monkeys.

Authors:  S Holzammer; E Holznagel; A Kaul; R Kurth; S Norley
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

2.  Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus.

Authors:  S Goldstein; I Ourmanov; C R Brown; B E Beer; W R Elkins; R Plishka; A Buckler-White; V M Hirsch
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.

Authors:  S R Broussard; S I Staprans; R White; E M Whitehead; M B Feinberg; J S Allan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys.

Authors:  O M Diop; A Gueye; M Dias-Tavares; C Kornfeld; A Faye; P Ave; M Huerre; S Corbet; F Barre-Sinoussi; M C Müller-Trutwin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry.

Authors:  S Pöhlmann; B Lee; S Meister; M Krumbiegel; G Leslie; R W Doms; F Kirchhoff
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  High levels of viral replication contrast with only transient changes in CD4(+) and CD8(+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx.

Authors:  Richard Onanga; Christopher Kornfeld; Ivona Pandrea; Jerome Estaquier; Sandrine Souquière; Pierre Rouquet; Virginie Poaty Mavoungou; Olivier Bourry; Souleymane M'Boup; Françoise Barré-Sinoussi; François Simon; Cristian Apetrei; Pierre Roques; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

Authors:  Guido Silvestri; Donald L Sodora; Richard A Koup; Mirko Paiardini; Shawn P O'Neil; Harold M McClure; Silvija I Staprans; Mark B Feinberg
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

9.  Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism.

Authors:  Armin Papkalla; Jan Münch; Claas Otto; Frank Kirchhoff
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 10.  Lessons learned from the natural hosts of HIV-related viruses.

Authors:  Mirko Paiardini; Ivona Pandrea; Cristian Apetrei; Guido Silvestri
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

View more
  28 in total

1.  Primary infection by a human immunodeficiency virus with atypical coreceptor tropism.

Authors:  Chunlai Jiang; Nicholas F Parrish; Craig B Wilen; Hui Li; Yue Chen; Jeffrey W Pavlicek; Anna Berg; Xiaozhi Lu; Hongshuo Song; John C Tilton; Jennifer M Pfaff; Elizabeth A Henning; Julie M Decker; M Anthony Moody; Mark S Drinker; Robert Schutte; Stephanie Freel; Georgia D Tomaras; Rebecca Nedellec; Donald E Mosier; Barton F Haynes; George M Shaw; Beatrice H Hahn; Robert W Doms; Feng Gao
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Novel adenoviruses in wild primates: a high level of genetic diversity and evidence of zoonotic transmissions.

Authors:  Diana Wevers; Sonja Metzger; Fred Babweteera; Marc Bieberbach; Christophe Boesch; Kenneth Cameron; Emmanuel Couacy-Hymann; Mike Cranfield; Maryke Gray; Laurie A Harris; Josephine Head; Kathryn Jeffery; Sascha Knauf; Felix Lankester; Siv Aina J Leendertz; Elizabeth Lonsdorf; Lawrence Mugisha; Andreas Nitsche; Patricia Reed; Martha Robbins; Dominic A Travis; Zinta Zommers; Fabian H Leendertz; Bernhard Ehlers
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

4.  Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites.

Authors:  Ivona Pandrea; Nicholas F Parrish; Kevin Raehtz; Thaidra Gaufin; Hannah J Barbian; Dongzhu Ma; Jan Kristoff; Rajeev Gautam; Fang Zhong; George S Haret-Richter; Anita Trichel; George M Shaw; Beatrice H Hahn; Cristian Apetrei
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

5.  IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation.

Authors:  Dominik Hotter; Matteo Bosso; Kasper L Jønsson; Christian Krapp; Christina M Stürzel; Atze Das; Elisabeth Littwitz-Salomon; Ben Berkhout; Alina Russ; Sabine Wittmann; Thomas Gramberg; Yue Zheng; Laura J Martins; Vicente Planelles; Martin R Jakobsen; Beatrice H Hahn; Ulf Dittmer; Daniel Sauter; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2019-06-04       Impact factor: 21.023

6.  High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys.

Authors:  Andrew B Wilks; James R Perry; Elizabeth P Ehlinger; Roland C Zahn; Robert White; Marie-Claire Gauduin; Angela Carville; Michael S Seaman; Joern E Schmitz; Sallie R Permar
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

7.  Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.

Authors:  Manickam Ashokkumar; Shambhu G Aralaguppe; Srikanth P Tripathy; Luke Elizabeth Hanna; Ujjwal Neogi
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

8.  Absence of frequent herpesvirus transmission in a nonhuman primate predator-prey system in the wild.

Authors:  Sripriya Murthy; Emmanuel Couacy-Hymann; Sonja Metzger; Kathrin Nowak; Helene De Nys; Christophe Boesch; Roman Wittig; Michael A Jarvis; Fabian H Leendertz; Bernhard Ehlers
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

9.  Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.

Authors:  Joshua D Amos; Jonathon E Himes; Lawrence Armand; Thaddeus C Gurley; David R Martinez; Lisa Colvin; Krista Beck; R Glenn Overman; Hua-Xin Liao; M Anthony Moody; Sallie R Permar
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

10.  Characterization of Simian Immunodeficiency Virus Variants Anatomically Compartmentalized in Plasma and Milk in Chronically Infected African Green Monkeys.

Authors:  Jonathon E Himes; Carrie Ho; Quang N Nguyen; Joshua D Amos; Haolin Xu; Cliburn Chan; Shein-Chung Chow; Christina Ochsenbauer; Zhanna Kaidarova; Sheila M Keating; Genevieve G Fouda; Sallie R Permar
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.